TG Therapeutics
TGTX
#2332
Rank
โ‚น514.07 B
Marketcap
โ‚น3,273
Share price
0.29%
Change (1 day)
180.02%
Change (1 year)

Revenue for TG Therapeutics (TGTX)

Revenue in 2024 (TTM): โ‚น27.71 Billion

According to TG Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น28.09 Billion. an increase over the revenue in the year 2023 that were of โ‚น19.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TG Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น28.22 B45.09%
2023 โ‚น19.45 B8343.66%
2022 โ‚น0.23 B-53.73%
2021 โ‚น0.49 B4378.71%
2020 โ‚น11.11 M2.56%
2019 โ‚น10.83 M1.99%
2018 โ‚น10.62 M9.44%
2017 โ‚น9.71 M-6.22%
2016 โ‚น10.35 M2.26%
2015 โ‚น10.12 M4.86%
2014 โ‚น9.65 M2.59%
2013 โ‚น9.41 M802.65%
2012 โ‚น1.04 M
2011 N/A
2010 N/A
2009 N/A
2000 โ‚น0.25 B379.44%
1999 โ‚น52.16 M-61.66%
1998 โ‚น0.13 B1054.06%
1997 โ‚น11.78 M9.32%
1996 โ‚น10.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น316.16 B 1,025.13%๐Ÿ‡ฎ๐Ÿ‡ณ India
โ‚น133.03 B 373.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland